Search

Issue
Title
Authors
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E.V., Danilova T.B.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
Antiagregantnaya terapiya u patsientov s sakharnym diabetom, perenesshikh mozgovoy insul't
Matkevich E.I., Grapov D.O., Maksimov M.L.
Znachenie antioksidantnoy terapii v lechenii diabeticheskoy polinevropatii
Galstyan K.O.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A.S., Kulidzhanyan N.K., Shurupova I.V., Trifonova T.A., Antsiferov M.B.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V.A., Peterkova V.A.
DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW
Antsiferov M.B., Antciferov M.B.
DIABETIC AUTONOMIC NEUROPATHY AND DIGESTIVE ORGANS
Pogromov A.P., Baturova V.Y., Pogromov A.P., Yu Baturova V.
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES
Antsiferov M.B., Koteshkova O.M., Kleymenova S.A., Antsiferov M.B., Koteshkova O.M., Kleimenko S.A.
WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS
Petunina N.A., Petunina N.A.
ANTIOXIDANT THERAPY OF DIABETIC POLYNEUROPATHY
Tabeeva G.R., Azimova Y.E., Tabeeva G., Azimova Y.
Advance - movement forward
Petunina N.A., Petunina N.
OPTIMIZATsIYa INSULINOTERAPII SAKhARNOGO DIABETA TIPA 1 V PERIOD BEREMENNOSTI
Demidova I.Y., Mel'nikova E.P., Arbatskaya N.Y., Ignatova N.G.
Insulin resistance and heart diseases: is there a relationship?
Drapkina O.M., Smirin V.I., Ivashkin V.T., Drapkina O.M., Smirin V.I., Ivaschkin V.T.
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL
Antsiferov M.B., Petraneva E.V., Anciferov M.B., Petraneva E.V.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M.B., Demidov N.A., Safronova T.I., Mishra O.A.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S.S., Apetova V.V.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
Experience of using the new ultrafast-acting insulin Fiasp® in patients on insulin pump therapy: a case report
Barsukov I.A., Demina A.A.
Predictors of severe course of disease and high mortality among patients with COVID-19 and diabetes mellitus
Ivanova M.Z., Zhurtova I.B., Sizhazheva S.K., Gubachikova A.M.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T.V., Lomonova T.V.
Features of the treatment of patients with type 2 diabetes mellitus and morbid obesity
Amosova M.V., Gurova O.Y., Fadeev V.V.
Statins and the risk of diabetes: an evidence-based review
Leonova M.V.
Potential drug interactions of oral hypoglycemic drugs that increase the risk of hypoglycemia
Pereverzev A.P., Ostroumova O.D., Tkacheva O.N.
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
Shorokhova P.B., Baranov V.L., Vorokhobina N.V., Shpilevaya O.S.
Apelin: biological and pathophysiological effects
Dolgikh Y.A., Verbovoy A.F.
Opportunities for prevention of changes in skin and oral mucosa in diabetes mellitus at the present stage
Verbovoy A.F., Sharonova L.A., Burakshayev S.A., Kotelnikova E.V., Smirnova T.V.
Energy metabolism corrector Mildronate®: interrelation of mechanisms of action and therapeutic effects
Dzerve V.Y.
ANGIOTENSIN II RECEPTOR BLOCKERS AND ENDOTHELIAL DYSFUNCTION: FOCUS ON NEPHROCEREBRAL INTERACTIONS
Murkamilov I.T., Aytbaev K.A., Yusupov F.A.
Modern approaches to the treatment of patients with type 2 diabetes mellitus
Antsiferov M.B., Fadeev V.V., Morgunova T.B.
PATHOGENETIC THERAPY OF DIABETIC POLYNEUROPATHY
Badalyan O.L., Savenkov A.A.
Vozmozhnosti primeneniya insulina detemir pri lechenii sakharnogo diabeta u beremennykh: dokazannye preimushchestva i perspektivy ispol'zovaniya
Ruyatkina L.A., Sorokin M.Y.
Vliyanie Aktovegina na reparatsiyu khronicheskikh ran razlichnoy etiologii
Dibirov M.D., Gadzhimuradov R.U., Khalidov O.K., Kakubava M.R., Polyanskiy M.V.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
Issledovanie ORIGIN (Outcome Reduction with Initial Glargine INtervention) 2 goda spustya: chto novogo?
Glinkina I.V.
FAKTORY RISKA RAZVITIYa OSTEOPOROZA
Akimova D.V.
TsENTRAL'NYY NESAKhARNYY DIABET: V ChEM SEKRET EFFEKTIVNOGO LEChENIYa?
Biryukova E.V.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E.V., Danilova T.B.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.A.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.E.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M.B., Biryukova E.V., Zilov A.V.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V.N., Nikitin V.G., Leval' P.S., Ermolova D.A., Molochnikov A.Y., Ermolov A.A.
HOW TO OVERCOME THE EFFECTS OF "HYPERGLYCEMIC" MEMORY?
Biryukova E.V., V Biryukova Y.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
DIABETIC GASTROENTEROPATHY: THE PATHOGENESIS AND DIFFERENTIAL TREATMENT APPROACH (LITERATURE REVIEW)
Demicheva T.P., Demicheva T.P.
INTENSIVE INSULIN THERAPY IN ACUTE CEREBROVASCULAR ACCIDENT
Demidova I.Y., Makova A.G., Demidova I.Y., Makova A.G.
DIABETIC NEPHROPATHY: DOES ANGIOTENSIN-CONVERTING ENZYME INHIBITORS MAINTAIN PRIORITY POSITION?
Fomin V.V., Pulin A.A., Saginova E.A., Fomun V.V., Pulin A.A., Saginova E.A.
INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS: A CHOICE AND AN INDIVIDUAL APPROACH
Biryukova Y.V., Biryukova E.V.
Thiazide diuretics and arterial hypertension: the history is going on
E Chazova I., Fomin V.V., Chazova I., Fomin V.
Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?
Nedosugova L.V., Nedosugova L.
KLINIChESKIE NABLYuDENIYa PATsIENTOV S OSTEOPOROZOM I ENDOKRINNOY PATOLOGIEY
Belyaeva E.A.
Peculiarities of antihypertensive therapy in metabolic syndrome and diabetes mellitus
Mychka V.B., Zhernakova Y.V., Chazova I.E., Michka V.B., Jernakova Y.V., Chazova I.E.
Do all we know about the thiazolidinediones, or what pioglitazone differs from rosiglitazone?
Mkrtumyan A.M., Mkrtumyan A.M.
301 - 354 of 354 Items << < 1 2 3 4 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies